Lebers Disease: People with Lebers disease, a rare inherited eye condition, should avoid vitamin B12 injections
Factor 4: Stability and the Usable Window This is the counterweight to the cost-per-mg argument
Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile
Research Applications of GHK-CU 50mg in Laboratory Settings The breadth of published research on this compound reflects its versatility as a laboratory research tool
Structured post-injection guidance protects patients and supports clinical accountability
Beyond GI benefits, supports healing throughout the body including tendons, ligaments, muscles, and joints through systemic distribution and growth factor modulation pathways